UBS AM Portfolio holdings
UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2301
Equity Bancshares
EQBK
$1B
| $1.03M | ﹤0.01% |
21,008
| – | – |
2024 Q2
8 quarters
|
|
2302
iShares MSCI Canada ETF
EWC
$7.45B
| $1.02M | ﹤0.01% |
17,742
-158,504
| -90% | -$9.17M |
2025 Q4
2 quarters
|
|
2303
AGNT Inc
AGNT
$648M
| $1.02M | ﹤0.01% |
187,921
-12,265
| -6% | -$67.6K |
2019 Q2
28 quarters
|
|
2304
Guardian Pharmacy Services
GRDN
$2.58B
| $1.02M | ﹤0.01% |
24,249
+1,464
| +6% | +$56.7K |
2025 Q3
3 quarters
|
|
2305
Schwab US Aggregate Bond ETF
SCHZ
$10.8B
| $1.01M | ﹤0.01% |
43,585
-1,694
| -4% | -$39.2K |
2026 Q1
1 quarter
|
|
2306
ASP Isotopes
ASPI
$327M
| $1M | ﹤0.01% |
161,219
+48,743
| +43% | +$287K |
2025 Q4
2 quarters
|
|
2307
Infleqtion Inc
INFQ
$2B
| $1M | ﹤0.01% |
+75,122
| New | +$1.03M |
2026 Q2
0 quarters
|
|
2308
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.6B
| $997K | ﹤0.01% |
24,515
| – | – |
2026 Q1
1 quarter
|
|
2309
BlackSky Technology
BKSY
$731M
| $994K | ﹤0.01% |
35,589
-3,805
| -10% | -$137K |
2025 Q3
3 quarters
|
|
2310
Sana Biotechnology
SANA
$769M
| $993K | ﹤0.01% |
284,472
+52,766
| +23% | +$170K |
2025 Q3
3 quarters
|
|
2311
Brandywine Realty Trust
BDN
$507M
| $989K | ﹤0.01% |
312,025
-197,347
| -39% | -$593K |
2025 Q4
2 quarters
|
|
2312
Amcor
AMCR
$21.9B
| $988K | ﹤0.01% |
22,799
-2,526,792
| -99% | -$100M |
2019 Q2
28 quarters
|
|
2313
Schwab US Large-Cap Growth ETF
SCHG
$61.6B
| $988K | ﹤0.01% |
29,198
-78,549
| -73% | -$2.6M |
2025 Q4
2 quarters
|
|
2314
Gladstone Commercial Corp
GOOD
$553M
| $987K | ﹤0.01% |
80,282
+79,618
| +11,991% | +$992K |
2019 Q2
28 quarters
|
|
2315
Five Star Bancorp
FSBC
$1.1B
| $984K | ﹤0.01% |
20,218
-669
| -3% | -$28.2K |
2024 Q2
8 quarters
|
|
2316
EverQuote
EVER
$828M
| $981K | ﹤0.01% |
41,237
+4,504
| +12% | +$82.5K |
2024 Q2
8 quarters
|
|
2317
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$906M
| $976K | ﹤0.01% |
45,252
-26,736
| -37% | -$751K |
2025 Q4
2 quarters
|
|
2318
SI-BONE Inc
SIBN
$951M
| $975K | ﹤0.01% |
59,736
-27,538
| -32% | -$393K |
2020 Q4
22 quarters
|
|
2319
Invesco S&P MidCap Momentum ETF
XMMO
$6.61B
| $972K | ﹤0.01% |
5,715
-736
| -11% | -$120K |
2025 Q4
2 quarters
|
|
2320
State Street SPDR S&P Dividend ETF
SDY
$22.3B
| $971K | ﹤0.01% |
6,382
-1,010
| -14% | -$150K |
2025 Q4
2 quarters
|
|
2321
Business First Bancshares
BFST
$1.03B
| $971K | ﹤0.01% |
31,600
+766
| +2% | +$21.6K |
2024 Q2
8 quarters
|
|
2322
Butterfly Network
BFLY
$1.71B
| $970K | ﹤0.01% |
115,220
-212,880
| -65% | -$1.1M |
2026 Q1
1 quarter
|
|
2323
DRDGold
DRD
$1.97B
| $966K | ﹤0.01% |
+45,373
| New | +$1.23M |
2026 Q2
0 quarters
|
|
2324
Zenas BioPharma
ZBIO
$1.85B
| $959K | ﹤0.01% |
37,790
+22,267
| +143% | +$443K |
2025 Q4
2 quarters
|
|
2325
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
| $952K | ﹤0.01% |
11,566
-542
| -4% | -$45.4K |
2025 Q4
2 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.